Answers are grounded in this paper and cite their sources.
The aim: is to improve gut microbiota composition by the long-term postbiotics (glycine and propionic acid) supplementation in patients with coronary artery disease (CAD) and atrial fibrillation (AF). Materials and methods: 40 patients were divided into 3 groups: first (CAD) – 14 patients with CAD but without arrhythmias; second (CAD+AF) – 18 patients with CAD and AF paroxysm; and the control group – 8 patients without CAD and arrhythmias. 16 patients from the II group received basic therapy, according to the latest ESC guidelines, and postbiotic supplementation: rebamipide (2-(4-chlorobenzoylamino)-3-[2(1H))-quinolon-4-yl] propionic acid) by 100 mg 3 times a day and glycine by 100 mg 3 times a day during 6 months. 16-S rRNA sequencing checked gut microbiota composition. Results: The II group patients had a significant rise in Pseudomonadota (by taxonomic analysis), Actinobacter Spp. and a decrease in Blautia Spp., Bacteroides Thetaiotaomicron compared with the I group, P<0.05. Long-term postbiotics supplementation for patients with coronary artery disease and atrial fibrillation leads to a significant decrease in Firmicutes/ Bacteroides ratio, P<0.05; a significant rise in Verrucomicrobiota and a decrease in Firmicutes, P<0.05; a significant increase in Lactobacillus spp., Akkermansia muciniphila, Blautia spp., Prevotella spp. and a decrease in Streptococcus spp. and Methanosphaera stadmanae, P<0.05. A significantly lower F/B ratio was found in the patients with long-term postbiotics supplementation in comparison with placebo group patients, P<0.05. A significant increase in Actinomycetota was found in the patients with long-term postbiotics supplementation compared to placebo group patients, P<0.05. A significant increase in probiotic species (Akkermansia muciniphila, Blautia spp., Eubacterium Rectale, and Prevotella spp.) and a decrease in species, associated with cardiometabolic disorders (Streptococcus spp.) was found in the patients with long term postbiotics supplementation in comparison with placebo group patients, P<0.05. Conclusion: Long-term postbiotics supplementation for patients with coronary artery disease and atrial fibrillation leads to positive gut microbiota modulation
No takes yet. Share an insight, caveat, or question.
I.O. Melnychuk (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: